Epigenetic silencing of HIV-1 by the histone H3 Lysine 27 methyltransferase enhancer of Zeste 2

Journal of Virology

Volumn 85, Issue 17, 2011, Pages 9078-9089

  Friedman, Julia ^a   Cho, Won Kyung ^a   Chu, Chung K ^b   Keedy, Kara S ^c   Archin, Nancie M ^c   Margolis, David M ^c   Karn, Jonathan ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF GEORGIA   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 DEAZANEPLANOCIN A; BIX 01294; CHETOCIN; HISTONE H3; HISTONE LYSINE METHYLTRANSFERASE; LYSINE; METHYLTRANSFERASE; POLYCOMB GROUP PROTEIN; POLYCOMB REPRESSIVE COMPLEX 2 PROTEIN; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR EZH2; TRIMETHYL HISTONE LYSINE 27; UNCLASSIFIED DRUG;

ARTICLE; CELL POPULATION; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; DRUG ACTIVITY; EPIGENETICS; GENE SILENCING; HISTONE METHYLATION; HUMAN IMMUNODEFICIENCY VIRUS; LATENT PERIOD; LEUKEMIA CELL LINE; LONG TERMINAL REPEAT; LYMPHOCYTE ACTIVATION; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN SYNTHESIS; PROTEIN TARGETING; PROVIRUS; T LYMPHOCYTE; VIRUS REACTIVATION;

CHROMATIN IMMUNOPRECIPITATION; DNA-BINDING PROTEINS; EPIGENESIS, GENETIC; GENE KNOCKDOWN TECHNIQUES; HISTONE-LYSINE N-METHYLTRANSFERASE; HISTONES; HIV INFECTIONS; HIV-1; HUMANS; JURKAT CELLS; LYSINE; TRANSCRIPTION FACTORS; VIRUS LATENCY;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 80052287096     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00836-11     Document Type: Article

References (80)

1. Archin, N. M., et al. 2009. Expression of latent HIV induced by the potent HDAC inhibitor suberoylanilide hydroxamic acid. AIDS Res. Hum. Retrovir. 25:207-212.
2. Archin, N. M., et al. 2009. Expression of latent human immunodeficiency type 1 is induced by novel and selective histone deacetylase inhibitors. AIDS 23:1799-1806.
3. Bernstein, B. E., et al. 2006. A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell 125:315-326.
4. Blazkova, J., et al. 2009. CpG methylation controls reactivation of HIV from latency. PLoS Pathog. 5:e1000554.
5. + T cells. Blood 113:58-65.
6. Boyer, L. A., et al. 2006. Polycomb complexes repress developmental regulators in murine embryonic stem cells. Nature 441:349-353.
7. Brennan, T. P., et al. 2009. Analysis of HIV-1 viremia and provirus in resting CD4+ T cells reveals a novel source of residual viremia in patients on antiretroviral therapy. J. Virol. 83:8470-8481.
8. Cao, R., and Y. Zhang. 2004. The functions of E(Z)/EZH2-mediated methylation of lysine 27 in histone H3. Curr. Opin. Genet. Dev. 14:155-164.
9. Cheng, A. S., et al. 2011. EZH2-mediated concordant repression of Wnt antagonists promotes β-catenin-dependent hepatocarcinogenesis. Cancer Res. 71:4028-4039.
10. Cherrier, T., et al. 2009. p21(WAF1) gene promoter is epigenetically silenced by CTIP2 and SUV39H1. Oncogene 28:3380-3389.
11. Chomont, N., et al. 2009. HIV reservoir size and persistence are driven by T cell survival and homeostatic proliferation. Nat. Med. 15:893-900.
12. Chun, T.-W., et al. 1998. Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection. Proc. Natl. Acad. Sci. U. S. A. 95:8869-8873.
13. Chun, T. W., R. T. Davey, Jr., D. Engel, H. C. Lane, and A. S. Fauci. 1999. Re-emergence of HIV after stopping therapy. Nature 401:874-875.
14. Chun, T. W., et al. 2005. HIV-infected individuals receiving effective antiviral therapy for extended periods of time continually replenish their viral reservoir. J. Clin. Invest. 115:3250-3255.
15. Contreras, X., M. Barboric, T. Lenasi, and B. M. Peterlin. 2007. HMBA releases P-TEFb from HEXIM1 and 7SK snRNA via PI3K/Akt and activates HIV transcription. PLoS Pathog. 3:1459-1469.
16. Contreras, X., et al. 2009. Suberoylanilide hydroxamic acid reactivates HIV from latently infected cells. J. Biol. Chem. 284:6782-6789.
17. Davey, R. T., Jr., et al. 1999. HIV-1 and T cell dynamics after interruption of highly active antiretroviral therapy (HAART) in patients with a history of sustained viral suppression. Proc. Natl. Acad. Sci. U. S. A. 96:15109-15114.
18. Dinoso, J. B., et al. 2009. Treatment intensification does not reduce residual HIV-1 viremia in patients on highly active antiretroviral therapy. Proc. Natl. Acad. Sci. U. S. A. 106:9403-9408.
19. du Chene, I., et al. 2007. Suv39H1 and HP1gamma are responsible for chromatin-mediated HIV-1 transcriptional silencing and post-integration latency. EMBO J. 26:424-435.
20. Enderle, D., et al. 2011. Polycomb preferentially targets stalled promoters of coding and noncoding transcripts. Genome Res. 21:216-226.
21. Finzi, D., et al. 1997. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 278:1295-1300.
22. Fiskus, W., et al. 2009. Combined epigenetic therapy with the histone methyltransferase EZH2 inhibitor 3-deazaneplanocin A and the histone deacetylase inhibitor panobinostat against human AML cells. Blood 114:2733-2743.
23. Fodor, B. D., N. Shukeir, G. Reuter, and T. Jenuwein. 2010. Mammalian Su(var) genes in chromatin control. Annu. Rev. Cell Dev. Biol. 26:471-501.
24. Fuks, F. 2005. DNA methylation and histone modifications: teaming up to silence genes. Curr. Opin. Genet. Dev. 15:490-495.
25. Greiner, D., T. Bonaldi, R. Eskeland, E. Roemer, and A. Imhof. 2005. Identification of a specific inhibitor of the histone methyltransferase SU(VAR)3-9. Nat. Chem. Biol. 1:143-145.
26. Gunther, T., and A. Grundhoff. 2010. The epigenetic landscape of latent Kaposi sarcoma-associated herpesvirus genomes. PLoS Pathog. 6:e1000935.
27. Hakre, S., L. Chavez, K. Shirakawa, and E. Verdin. 2011. Epigenetic regulation of HIV latency. Curr. Opin. HIV AIDS 6:19-24.
28. Han, Y., et al. 2004. Resting CD4+ T cells from human immunodeficiency virus type 1 (HIV-1)-infected individuals carry integrated HIV-1 genomes within actively transcribed host genes. J. Virol. 78:6122-6133.
29. Han, Y., et al. 2008. Orientation-dependent regulation of integrated HIV-1 expression by host gene transcriptional readthrough. Cell Host Microbe 4:134-146.
30. Imai, K., H. Togami, and T. Okamoto. 2010. Involvement of histone H3 lysine 9 (H3K9) methyltransferase G9a in the maintenance of HIV-1 latency and its reactivation by BIX01294. J. Biol. Chem. 285:16538-16545.
31. Joos, B., et al. 2008. HIV rebounds from latently infected cells, rather than from continuing low-level replication. Proc. Natl. Acad. Sci. U. S. A. 105:16725-16730.
32. Jordan, A., D. Bisgrove, and E. Verdin. 2003. HIV reproducibly establishes a latent infection after acute infection of T cells in vitro. EMBO J. 22:1868-1877.
33. Kaneko, S., et al. 2010. Phosphorylation of the PRC2 component Ezh2 is cell cycle-regulated and up-regulates its binding to ncRNA. Genes Dev. 24:2615-2620.
34. Kanhere, A., et al. 2010. Short RNAs are transcribed from repressed polycomb target genes and interact with polycomb repressive complex-2. Mol. Cell 38:675-688.
35. Karn, J. 2011. The molecular biology of HIV latency: breaking and restoring the Tat-dependent transcriptional circuit. Curr. Opin. HIV AIDS 6:4-11.
36. Kauder, S. E., A. Bosque, A. Lindqvist, V. Planelles, and E. Verdin. 2009. Epigenetic regulation of HIV-1 latency by cytosine methylation. PLoS Pathog. 5:e1000495.
37. Kim, Y. K., et al. 2006. Recruitment of TFIIH to the HIV LTR is a ratelimiting step in the emergence of HIV from latency. EMBO J. 25:3596-3604.
38. Kim, Y. K., U. Mbonye, J. Hokello, and J. Karn. 2011. T-cell receptor signaling enhances transcriptional elongation from latent HIV proviruses by activating P-TEFb through an ERK-dependent pathway. J. Mol. Biol. 410:896-916.
39. Kinoshita, S., et al. 1997. The T cell activation factor NF-ATc positively regulates HIV-1 replication and gene expression in T cells. Immunity 6:235-244.
40. Kouzarides, T. 2002. Histone methylation in transcriptional control. Curr. Opin. Genet. Dev. 12:198-209.
41. Koyanagi, M., et al. 2005. EZH2 and histone 3 trimethyl lysine 27 associated with Il4 and Il13 gene silencing in Th1 cells. J. Biol. Chem. 280:31470-31477.
42. Ku, M., et al. 2008. Genomewide analysis of PRC1 and PRC2 occupancy identifies two classes of bivalent domains. PLoS Genet. 4:e1000242.
43. Kutsch, O., E. N. Benveniste, G. M. Shaw, and D. N. Levy. 2002. Direct and quantitative single-cell analysis of human immunodeficiency virus type 1 reactivation from latency. J. Virol. 76:8776-8786.
44. Kuzmichev, A., K. Nishioka, H. Erdjument-Bromage, P. Tempst, and D. Reinberg. 2002. Histone methyltransferase activity associated with a human multiprotein complex containing the Enhancer of Zeste protein. Genes Dev. 16:2893-2905.
45. Kwiatkowski, D. L., H. W. Thompson, and D. C. Bloom. 2009. The polycomb group protein Bmi1 binds to the herpes simplex virus 1 latent genome and maintains repressive histone marks during latency. J. Virol. 83:8173-8181.
46. Lehrman, G., et al. 2005. Depletion of latent HIV-1 infection in vivo: a proof-of-concept study. Lancet 366:549-555.
47. Lenasi, T., X. Contreras, and B. M. Peterlin. 2008. Transcriptional interference antagonizes proviral gene expression to promote HIV latency. Cell Host Microbe 4:123-133.
48. Lewinski, M. K., et al. 2006. Retroviral DNA integration: viral and cellular determinants of target-site selection. PLoS Pathog. 2:e60.
49. Li, G., et al. 2010. Jarid2 and PRC2, partners in regulating gene expression. Genes Dev. 24:368-380.
50. Lu, F., W. Stedman, M. Yousef, R. Renne, and P. M. Lieberman. 2010. Epigenetic regulation of Kaposi's sarcoma-associated herpesvirus latency by virus-encoded microRNAs that target Rta and the cellular Rbl2-DNMT pathway. J. Virol. 84:2697-2706.
51. Lusic, M., A. Marcello, A. Cereseto, and M. Giacca. 2003. Regulation of HIV-1 gene expression by histone acetylation and factor recruitment at the LTR promoter. EMBO J. 22:6550-6561.
52. Mahmoudi, T., et al. 2006. The SWI/SNF chromatin-remodeling complex is a cofactor for tat transactivation of the HIV promoter. J. Biol. Chem. 281:19960-19968.
53. Marban, C., et al. 2007. Recruitment of chromatin-modifying enzymes by CTIP2 promotes HIV-1 transcriptional silencing. EMBO J. 26:412-423.
54. Margolis, D. M. 2010. Mechanisms of HIV latency: an emerging picture of complexity. Curr. HIV/AIDS Rep. 7:37-43.
55. Margueron, R., and D. Reinberg. 2011. The Polycomb complex PRC2 and its mark in life. Nature 469:343-349.
56. Miranda, T. B., et al. 2009. DZNep is a global histone methylation inhibitor that reactivates developmental genes not silenced by DNA methylation. Mol. Cancer Ther. 8:1579-1588.
57. Naldini, L., et al. 1996. In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272:263-267.
58. Nguyen, V. T., T. Kiss, A. A. Michels, and O. Bensaude. 2001. 7SK small nuclear RNA binds to and inhibits the activity of CDK9/cyclin T complexes. Nature 414:322-325.
59. Pasini, D., et al. 2010. JARID2 regulates binding of the Polycomb repressive complex 2 to target genes in ES cells. Nature 464:306-310.
60. Pearson, R., et al. 2008. Epigenetic silencing of human immunodeficiency virus (HIV) transcription by formation of restrictive chromatin structures at the viral long terminal repeat drives the progressive entry of HIV into latency. J. Virol. 82:12291-12303.
61. Raaphorst, F. M., et al. 2001. Distinct BMI-1 and EZH2 expression patterns in thymocytes and mature T cells suggest a role for Polycomb genes in human T cell differentiation. J. Immunol. 166:5925-5934.
62. Richman, D. D., et al. 2009. The challenge of finding a cure for HIV infection. Science 323:1304-1307.
63. Sewalt, R. G., et al. 2002. Selective interactions between vertebrate Polycomb homologs and the SUV39H1 histone lysine methyltransferase suggest that histone H3-K9 methylation contributes to chromosomal targeting of Polycomb group proteins. Mol. Cell. Biol. 22:5539-5553.
64. Siliciano, J. D., et al. 2003. Long-term follow-up studies confirm the stability of the latent reservoir for HIV-1 in resting CD4+ T cells. Nat. Med. 9:727-728.
65. Sun, F., et al. 2009. Combinatorial pharmacologic approaches target EZH2-mediated gene repression in breast cancer cells. Mol. Cancer Ther. 8:3191-3202.
66. Tae, S., et al. 29 March 2011. Bromodomain protein 7 interacts with PRMT5 and PRC2, and is involved in transcriptional repression of their target genes. Nucleic Acids Res. [Epub ahead of print.]
67. Toth, Z., et al. 2010. Epigenetic analysis of KSHV latent and lytic genomes. PLoS Pathog. 6:e1001013.
68. Trojer, P., and D. Reinberg. 2007. Facultative heterochromatin: is there a distinctive molecular signature? Mol. Cell 28:1-13.
69. Trono, D., et al. 2010. HIV persistence and the prospect of long-term drugfree remissions for HIV-infected individuals. Science 329:174-180.
70. Tsai, M. C., et al. 2010. Long noncoding RNA as modular scaffold of histone modification complexes. Science 329:689-693.
71. Tyagi, M., and J. Karn. 2007. CBF-1 promotes transcriptional silencing during the establishment of HIV-1 latency. EMBO J. 26:4985-4995.
72. Tyagi, M., R. J. Pearson, and J. Karn. 2010. Establishment of HIV latency in primary CD4+ cells is due to epigenetic transcriptional silencing and P-TEFb restriction. J. Virol. 84:6425-6437.
73. Vire, E., et al. 2006. The Polycomb group protein EZH2 directly controls DNA methylation. Nature 439:871-874.
74. Volberding, P. A., and S. G. Deeks. 2010. Antiretroviral therapy and management of HIV infection. Lancet 376:49-62.
75. Williams, S. A., et al. 2006. NF-ΚB p50 promotes HIV latency through HDAC recruitment and repression of transcriptional initiation. EMBO J. 25:139-149.
76. Williams, S. A., H. Kwon, L. F. Chen, and W. C. Greene. 2007. Sustained induction of NF-ΚB is required for efficient expression of latent human immunodeficiency virus type 1. J. Virol. 81:6043-6056.
77. Yamaguchi, J., et al. 2010. Histone deacetylase inhibitor (SAHA) and repression of EZH2 synergistically inhibit proliferation of gallbladder carcinoma. Cancer Sci. 101:355-362.
78. Yang, Z., Q. Zhu, K. Luo, and Q. Zhou. 2001. The 7SK small nuclear RNA inhibits the CDK9/cyclin T1 kinase to control transcription. Nature 414:317-22.
79. Ylisastigui, L., N. M. Archin, G. Lehrman, R. J. Bosch, and D. M. Margolis. 2004. Coaxing HIV-1 from resting CD4 T cells: histone deacetylase inhibition allows latent viral expression. AIDS 18:1101-1108.
80. Zhou, M., et al. 2004. Coordination of transcription factor phosphorylation and histone methylation by the P-TEFb kinase during human immunodeficiency virus type 1 transcription. J. Virol. 78:13522-13533.